Oyster Point Pharma

-$0.10 (-0.67%) As of 5:45 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell OYST and other ETFs, options, and stocks.

About OYST

Oyster Point Pharma, Inc. engages in the development and commercialization of pharmaceutical therapies to treat ocular surface diseases. Its product candidate, OC-01, is a nicotinic acetylcholine receptor agonist, which is being developed as a nasal spray to treat the signs and symptoms of dry eye disease.

CEO
Jeffrey A. Nau
Employees
62
Headquarters
Princeton, New Jersey
Founded
2015

OYST Key Statistics

Market Cap
436.37M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
55.29K
High Today
$14.65
Low Today
$14.16
Open Price
$14.25
Volume
37.92K
52 Week High
$28.00
52 Week Low
$14.16

OYST Earnings

-$1.41
-$0.94
-$0.47
$0.00
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 13, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure